NCT07384299Completed
Impact of Skin Type on Wonud Healing and Scarring Following Facial Skin Surgery
Impact of Baumann Skin Type on Wound Healing and Scar Formation Following Facial Skin Surgery
Source: ClinicalTrials.gov · Last updated 3 Feb 2026
Brief summary (registry, in English)
The goal of this observational study is to learn how an individual's skin type influences the wound healing process and scar formation in Chinese patients undergoing facial dermatologic surgery. The main questions it aims to answer are: How does skin type affect the quality of wound healing after facial surgery? How does skin type affect the formation of hypertrophic scars after facial surgery? Researchers will compare groups of patients with different skin types (classified by the Baumann Skin Type) to see if there are significant differences in their healing outcomes and scar characteristics. Participants in this study will: Receive standard facial dermatologic surgery as part of their clinical care. Have their skin type assessed preoperatively. Undergo scheduled postoperative follow-up assessments at 7 and 90 days to evaluate wound healing and scar development using standardized scales.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 173 (actual)
- First submitted
- 18 Jan 2026
- Start date
- 15 Jun 2025
- Primary completion date
- 15 Jan 2026
- Lead sponsor
- Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
- NCT number
- NCT07384299
What you commit to
- Study type: Observational
- Participants enrolled: 173
- From 15 Jun 2025 to the primary completion date, 15 Jan 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Surgical site located on or adjacent to the mucosal surface.
- Current use of medications affecting wound healing or scar formation (e.g., long-term systemic corticosteroids, immunosuppressants).
- Concurrent participation in another interventional clinical trial.
Other illness
- Clinically or postoperatively diagnosed with a facial malignant tumor.
- Known history of allergy to any medications or dressings to be used during or after surgery.
- Presence of systemic diseases that significantly impair wound healing (e.g., poorly controlled diabetes, immunodeficiency disorders, active infections).
- Any other condition deemed by the investigator as likely to interfere with study results or increase participant risk.
Other
- Wounds requiring staged excision or planned for secondary intention healing.
- Pregnancy or lactation.
- Refusal to provide written informed consent, or anticipated inability to comply with study follow-up and data collection.
Who the study is looking for
- Aged between 14 and 60 years.
- Clinically and postoperatively pathologically diagnosed with a facial benign tumor (e.g., melanocytic nevus, sebaceous cyst, seborrheic keratosis, etc.) and having undergone standard surgical treatment.
- Voluntary participation in this study with written informed consent obtained.
- Commitment to comply with all study protocols and to complete all follow-up visits and data collection procedures.
Age in the registry: 14 years to 60 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Not Appicable Coordinator of this site? Confirm its status | Wuhan | China | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.